Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Anaplastic Thyroid Cancer: Proof-of-Concept Study
2017-003028-59Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anakinra in anaplastic thyroid cancer (ATC), sponsored by Radboud University Medical Center. Primary endpoint: Health Related Quality of Life (ATC-specific). Started Mar 2018; status: active.
02
Drugs
anakinra
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on 2017-003028-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003028-59.